Claude Sonnet 5 autonomously chose gene therapy and brain surgery on an epileptic mouse
🤖 AI-generated content — The title and summary were produced automatically by artificial intelligence, without human editorial review.
Gabriel Ocana-Santero of Exin Therapeutics said Claude Sonnet 5, given 19 gene therapies and a camera-equipped surgical device for an epilepsy mouse model, picked the drug, brain target, and injection coordinates on its own—the first autonomous treatment choice and delivery in a living mammal. During the procedure it made 32 camera-based observations, then halted and refused to override a safety restriction after a calibration error.
Continue in the app — vote & join in ➔Source: The Decoder (AI) · via ahirlevel.hu